LIVE

ONC

BeOne Medicines AG

ONC

NASDAQ·Healthcare·Biotechnology·Mkt cap $31.1B

$293.77

+1.04%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$240.00 - $385.22

P/E

11.02

Fwd P/E

30.57

Beta

0.49

Div Yield

0.00%

Avg Vol

249.8K

Shares Out

Mkt Cap

$31.1B

Price action

Price chart

Up 19.0% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

No bull reasons captured for this rating yet.

Bear Case

2 risks

  • Low volatility (beta 0.5).
  • Significant premium - growth priced in

Growth

Strong growth ahead

Value

Significant premium - growth priced in

Momentum

Weak

-6.5% over 3m

Quality

Excellent

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Aug 5, 2026

LATEST RECAP

Earnings recap unavailable for this period.

EPS surprise · last 4Q

Q1 26

$26.65

Next: Aug 5, 2026

Revenue trend · last 1Q

Q1 26

$1.5B

Margins · last 1Q

Profit

15.0%

Wall Street consensus

6 analysts · 83% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

5

83%

Hold

1

17%

Sell

0%

Median Price Target

$409.00

+39.2% vs $293.77

Low $367.00
Median $409.00
High $436.00

Latest: RBC Capital · $436.00 · Jun 2, 2026

7 analysts covering

vs Industry

How ONC stacks vs Biotechnology

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.

Related

Peers & themes

Peers

No peer data available.

Themes

No themes assigned.